Biotechpharma, UAB - financials and debts

Company age: 22 y. 2 mo.

Update

Biotechnologinės farmacijos centras Biotechpharma - Company finances

  • The company is late in submitting financial data for the previous financial year.
  • Latest financial data up to 2024-12-31.
EUR
2018
From: 2018-01-01
To: 2018-12-31
2019
From: 2019-01-01
To: 2019-12-31
2020
From: 2020-01-01
To: 2020-12-31
2021
From: 2021-01-01
To: 2021-12-31
2022
From: 2022-01-01
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
Financial data
Sales revenue 28,743,994 37,702,884 45,564,702 76,153,418 123,919,188 93,045,600 74,035,286
Profit before tax 9,588,309 15,959,865 20,920,218 34,384,439 60,120,244 50,779,570 45,581,203
Net profit 9,588,309 15,959,865 20,920,218 34,384,439 60,120,244 50,779,570 45,581,203
Equity 10,953,434 17,324,990 30,265,275 54,189,605 97,117,629 94,214,496 114,940,959
Liabilities 13,231,576 12,401,820 36,658,151 67,622,662 58,745,860 61,164,150 61,271,818
Non-current assets 22,073,574 22,123,576 55,621,007 56,206,419 85,544,582 56,086,298 83,999,105
Current assets 13,632,588 20,431,314 22,060,947 77,526,267 82,060,375 110,169,310 102,556,891
Total assets 35,706,162 42,554,890 77,681,954 133,732,686 167,604,957 166,255,608 186,555,996
Taxes paid
STI taxes - - - - - - 893,946
Social insurance contributions - - - - - 1,542,001 1,156,382
Financial indicators
Revenue change y/y +38.3% +31.2% +20.9% +67.1% +62.7% -24.9% -20.4%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. 26.9% 37.5% 26.9% 25.7% 35.9% 30.5% 24.4%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. 87.5% 92.1% 69.1% 63.5% 61.9% 53.9% 39.7%
Profit margin Net profit margin. Shows the overall profitability of the company. 33.4% 42.3% 45.9% 45.2% 48.5% 54.6% 61.6%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. 33.4% 42.3% 45.9% 45.2% 48.5% 54.6% 61.6%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. 1.2 0.7 1.2 1.2 0.6 0.6 0.5
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. 225,002 301,422 352,077 447,303 710,139 579,122 648,484

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

Sales revenue

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

Biotechnologinės farmacijos centras Biotechpharma - Social security debts

From To Debt, €
2026-06-16 2026-06-18 1261.84
2023-07-18 2023-07-20 6124.03

Biotechnologinės farmacijos centras Biotechpharma - VMI tax arrears

The company had no tax arrears (debts) to the State Tax Inspectorate

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.